Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/7/16 → 04/3/19 |
Funding
- Regeneron Pharmaceuticals Incorporated: $11,963.00
A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients with Moderately Severe to Severe Nonproliferative Diabetic Retinopathy
- Chaudhary, Khurram (CoPI)
- El Baba, Fadi (PI)
Project: Research